DRSK Stock Summary and Trading Ideas (Aptus Defined Risk ETF | BATS:DRSK)

The Fund is an actively-managed ETF that seeks to achieve its objective through a hybrid fixed income and equity strategy. The Fund typically invests approximately 90% to 95% of its assets to obtain exposure to investment-grade corporate bonds (the Fixed Income Strategy) and invests the remainder of its assets to obtain exposure to large capitalization U.S. stocks, while limiting downside risk (the Equity Strategy). The Fund s Fixed Income Strategy seeks exposure to U.S. dollar-denominated, investment-grade corporate bonds of U.S. and non-U.S. issuers with maturities roughly evenly spaced across each of the next seven to eight years (also known as a bond ladder). The Fund will primarily obtain this exposure through investments in ETFs (Underlying Bond ETFs) that each track the investment results of an index composed of such bonds maturing in a specified year during that period (e.g., bonds maturing in 2023). The Fund s Equity Strategy seeks exposure to large capitalization U.S. stocks by purchasing at-the-money, exchange-listed call options on approximately ten to twenty individual stocks (the Underlying Individual Equities) or on one or more other ETFs that principally invest in large capitalization U.S. equity securities (the Underlying Equity ETFs).

Aptus Defined Risk ETF trades on the BATS stock market under the symbol DRSK.

As of March 4, 2025, DRSK stock price declined to $28.16 with 380,373 million shares trading.

DRSK has a beta of 0.43, meaning it tends to be less sensitive to market movements. DRSK has a correlation of 0.51 to the broad based SPY ETF.

DRSK has a market cap of $1.13 billion. This is considered a Small Cap stock.

In the last 3 years, DRSK traded as high as $29.24 and as low as $22.71.

DRSK has underperformed the market in the last year with a return of +10.4%, while SPY returned +13.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DRSK shares. However, DRSK has outperformed the market in the last 3 month and 2 week periods, returning +2.1% and +0.2%, while SPY returned -4.2% and -5.5%, respectively. This indicates DRSK has been having a stronger performance recently.

DRSK support price is $27.99 and resistance is $28.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DRSK shares will trade within this expected range on the day.